Related Articles
Hsp90 inhibition increases p53 expression and destabilizes MYCN and MYC in neuroblastoma
Biological effects of induced MYCN hyper-expression in MYCN-amplified neuroblastomas
Destabilization of MYC/MYCN by the mitochondrial inhibitors, metaiodobenzylguanidine, metformin and phenformin
High level MycN expression in non-MYCN amplified neuroblastoma is induced by the combination treatment nutlin-3 and doxorubicin and enhances chemosensitivity
Keratoepithelin reverts the suppression of tissue factor pathway inhibitor 2 by MYCN in human neuroblastoma: A mechanism to inhibit invasion